| Wistar Moore Iii, MD | |
|
801 E 6th St Ste 307, Panama City, FL 32401-3663 | |
| (850) 785-9559 | |
| (850) 608-6423 |
| Full Name | Wistar Moore Iii |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 39 Years |
| Location | 801 E 6th St Ste 307, Panama City, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326076274 | NPI | - | NPPES |
| 375218600 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | ME64685 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Sacred Heart Bay | Panama city, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sacred Heart Health System Inc | 3779491386 | 355 |
News Archive
HAIR loss is one of the most distressing side-effects of cancer treatment and can even deter some patients from undergoing life-saving chemotherapy. But researchers at the University of Huddersfield are establishing the scientific basis for a rapidly-advancing scalp cooling technology that can ensure hair retention in a vast number of cases.
Researchers in Canada have established a new university/industry network to pursue the development of biomaterials, medical devices and drug delivery systems to treat the increasing incidence of eye disease.
Oct. 1 marked the official end to this year's effort to "repeal and replace" the Affordable Care Act. But the start of fiscal 2018 also marked the end of the federal authorization for the popular Children's Health Insurance Program.
The risks of death are probably higher with aprotinin, a drug commonly used to control blood loss and transfusions during cardiac surgery, compared with lysine analogues, according to a study to be published in the January 20th issue of CMAJ.
Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial results for the three and nine months ended September 30, 2009.
› Verified 7 days ago
| Entity Name | Florida Hospital Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225034234 PECOS PAC ID: 0749186153 Enrollment ID: O20031208000807 |
News Archive
HAIR loss is one of the most distressing side-effects of cancer treatment and can even deter some patients from undergoing life-saving chemotherapy. But researchers at the University of Huddersfield are establishing the scientific basis for a rapidly-advancing scalp cooling technology that can ensure hair retention in a vast number of cases.
Researchers in Canada have established a new university/industry network to pursue the development of biomaterials, medical devices and drug delivery systems to treat the increasing incidence of eye disease.
Oct. 1 marked the official end to this year's effort to "repeal and replace" the Affordable Care Act. But the start of fiscal 2018 also marked the end of the federal authorization for the popular Children's Health Insurance Program.
The risks of death are probably higher with aprotinin, a drug commonly used to control blood loss and transfusions during cardiac surgery, compared with lysine analogues, according to a study to be published in the January 20th issue of CMAJ.
Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial results for the three and nine months ended September 30, 2009.
› Verified 7 days ago
| Entity Name | Sacred Heart Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962453308 PECOS PAC ID: 3779491386 Enrollment ID: O20051015000049 |
News Archive
HAIR loss is one of the most distressing side-effects of cancer treatment and can even deter some patients from undergoing life-saving chemotherapy. But researchers at the University of Huddersfield are establishing the scientific basis for a rapidly-advancing scalp cooling technology that can ensure hair retention in a vast number of cases.
Researchers in Canada have established a new university/industry network to pursue the development of biomaterials, medical devices and drug delivery systems to treat the increasing incidence of eye disease.
Oct. 1 marked the official end to this year's effort to "repeal and replace" the Affordable Care Act. But the start of fiscal 2018 also marked the end of the federal authorization for the popular Children's Health Insurance Program.
The risks of death are probably higher with aprotinin, a drug commonly used to control blood loss and transfusions during cardiac surgery, compared with lysine analogues, according to a study to be published in the January 20th issue of CMAJ.
Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial results for the three and nine months ended September 30, 2009.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wistar Moore Iii, MD 4205 Belfort Rd Ste 4015, Jacksonville, FL 32216-3623 Ph: (904) 450-6063 | Wistar Moore Iii, MD 801 E 6th St Ste 307, Panama City, FL 32401-3663 Ph: (850) 785-9559 |
News Archive
HAIR loss is one of the most distressing side-effects of cancer treatment and can even deter some patients from undergoing life-saving chemotherapy. But researchers at the University of Huddersfield are establishing the scientific basis for a rapidly-advancing scalp cooling technology that can ensure hair retention in a vast number of cases.
Researchers in Canada have established a new university/industry network to pursue the development of biomaterials, medical devices and drug delivery systems to treat the increasing incidence of eye disease.
Oct. 1 marked the official end to this year's effort to "repeal and replace" the Affordable Care Act. But the start of fiscal 2018 also marked the end of the federal authorization for the popular Children's Health Insurance Program.
The risks of death are probably higher with aprotinin, a drug commonly used to control blood loss and transfusions during cardiac surgery, compared with lysine analogues, according to a study to be published in the January 20th issue of CMAJ.
Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial results for the three and nine months ended September 30, 2009.
› Verified 7 days ago
Norman Reed Finney, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 801 E 6th Street, Suite 309, Panama City, FL 32401 Phone: 850-785-9559 Fax: 850-785-1136 | |
Gregory James England, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 801 E 6th Street, Suite 309, Panama City, FL 32401 Phone: 850-785-9559 Fax: 850-770-3026 | |
Lynn S Seto, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 619 N Cove Blvd, Panama City, FL 32401 Phone: 850-785-9559 Fax: 850-770-3026 | |
John Michael Kessinger, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 801 E 6th Street, Suite 309, Panama City, FL 32401 Phone: 850-785-9559 Fax: 850-785-1136 | |
Richard S Eubanks Jr., M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 801 E 6th St Ste 307, Panama City, FL 32401 Phone: 850-804-3823 Fax: 850-608-6423 |